Active, not recruitingNCT06741423
Distinguishing Retroperitoneal Fibrosis and Sarcoma from Other Retroperitoneal Diseases Via Radiomics
Studying IgG4-related retroperitoneal fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Heidelberg University
- Intervention
- Radiomics Algortihm(other)
- Enrollment
- 600 target
- Eligibility
- All sexes
- Timeline
- 2023 – 2025
Study locations (2)
- Peking University International Hospital, Beijing, China
- Universitätsklinikum Mannheim, Mannheim, Baden-Wurttemberg, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06741423 on ClinicalTrials.govOther trials for IgG4-related retroperitoneal fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT05428826Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal FibrosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT04314323National Registry of IRPF in ChinaPeking Union Medical College Hospital
- RECRUITINGNCT04312854A Prospective Cohort Study of IRPF in ChinaPeking Union Medical College Hospital
- RECRUITINGPHASE2, PHASE3NCT04047576Study of Sirolimus in Idiopathic Retroperitoneal FibrosisPeking University International Hospital